{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:24:53Z","timestamp":1793532293864,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5047\/A21332, C5047\/A13232 and C5047\/A17528"],"award-info":[{"award-number":["C5047\/A21332, C5047\/A13232 and C5047\/A17528"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","award":["CEO13_2-002"],"award-info":[{"award-number":["CEO13_2-002"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Ronald and Rita McAulay Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,9,21]]},"DOI":"10.1038\/s41416-025-03085-3","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:56:34Z","timestamp":1751450194000},"page":"615-624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1\/2 mutation carriers"],"prefix":"10.1038","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5260-965X","authenticated-orcid":false,"given":"R. L.","family":"Flaherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-6953","authenticated-orcid":false,"given":"M.","family":"Falcinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5220-8733","authenticated-orcid":false,"given":"A. R.","family":"Hesketh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3698-6241","authenticated-orcid":false,"given":"R.","family":"Eeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of The IMPACT Study Steering Committee and Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5311-3023","authenticated-orcid":false,"given":"M. S.","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"3085_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1158\/0008-5472.CAN-24-0628","volume":"84","author":"C Magnon","year":"2024","unstructured":"Magnon C. Cancer Builds a Noxious Partnership with Psychologic Stress. Cancer Res. 2024;84:956\u20137.","journal-title":"Cancer Res"},{"key":"3085_CR2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/ncponc1134","volume":"5","author":"Y Chida","year":"2008","unstructured":"Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pr Oncol. 2008;5:466\u201375.","journal-title":"Nat Clin Pr Oncol"},{"key":"3085_CR3","doi-asserted-by":"publisher","first-page":"j108","DOI":"10.1136\/bmj.j108","volume":"356","author":"GD Batty","year":"2017","unstructured":"Batty GD, Russ TC, Stamatakis E, Kivimaki M. Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. BMJ. 2017;356:j108.","journal-title":"BMJ"},{"key":"3085_CR4","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1038\/s41380-020-00865-6","volume":"25","author":"X Wang","year":"2020","unstructured":"Wang X, Wang N, Zhong L, Wang S, Zheng Y, Yang B, et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Mol Psychiatry. 2020;25:3186\u201397.","journal-title":"Mol Psychiatry"},{"key":"3085_CR5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s10897-016-9949-6","volume":"25","author":"J Ringwald","year":"2016","unstructured":"Ringwald J, Wochnowski C, Bosse K, Giel KE, Sch\u00e4ffeler N, Zipfel S, et al. Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1\/2 Mutation Carriers: a Systematic Review. J Genet Couns. 2016;25:880\u201391.","journal-title":"J Genet Couns"},{"key":"3085_CR6","doi-asserted-by":"publisher","first-page":"101033","DOI":"10.1016\/j.gore.2022.101033","volume":"42","author":"KE Dibble","year":"2022","unstructured":"Dibble KE, Donorfio LKM, Britner PA, Bellizzi KM. Stress, anxiety, and health-related quality of life in BRCA1\/2-positive women with and without cancer: A comparison of four US female samples. Gynecologic Oncol Rep. 2022;42:101033.","journal-title":"Gynecologic Oncol Rep"},{"key":"3085_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.psym.2012.06.007","volume":"53","author":"L Wenzel","year":"2012","unstructured":"Wenzel L, Osann K, Lester J, Kurz R, Hsieh S, Nelson EL, et al. Biopsychological stress factors in BRCA mutation carriers. Psychosomatics. 2012;53:582\u201390.","journal-title":"Psychosomatics"},{"key":"3085_CR8","doi-asserted-by":"crossref","unstructured":"Falcinelli M, Thaker PH, Lutgendorf SK, Conzen SD, Flaherty RL, Flint MS. The role of psychological stress in cancer initiation: clinical relevance and potential molecular mechanisms. Cancer Res. 2021: canres.0684.2021.","DOI":"10.1158\/0008-5472.CAN-21-0684"},{"key":"3085_CR9","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/bjc.2015.133","volume":"112","author":"A Reeder","year":"2015","unstructured":"Reeder A, Attar M, Nazario L, Bathula C, Zhang A, Hochbaum D, et al. Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage. Br J Cancer. 2015;112:1461\u201370.","journal-title":"Br J Cancer"},{"key":"3085_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.psyneuen.2007.02.013","volume":"32","author":"MS Flint","year":"2007","unstructured":"Flint MS, Baum A, Chambers WH, Jenkins FJ. Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones. Psychoneuroendocrinology. 2007;32:470\u20139.","journal-title":"Psychoneuroendocrinology"},{"key":"3085_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0823-8","volume":"19","author":"RL Flaherty","year":"2017","unstructured":"Flaherty RL, Owen M, Fagan-Murphy A, Intabli H, Healy D, Patel A, et al. Glucocorticoids induce production of reactive oxygen species\/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer. Breast Cancer Res. 2017;19:35.","journal-title":"Breast Cancer Res"},{"key":"3085_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.dnarep.2015.03.002","volume":"30","author":"R Fridlich","year":"2015","unstructured":"Fridlich R, Annamalai D, Roy R, Bernheim G, Powell SN. BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication. DNA Repair (Amst). 2015;30:11\u201320.","journal-title":"DNA Repair (Amst)"},{"key":"3085_CR13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.devcel.2022.05.003","volume":"57","author":"GK Gray","year":"2022","unstructured":"Gray GK, Li CM-C, Rosenbluth JM, Selfors LM, Girnius N, Lin J-R, et al. A human breast atlas integrating single-cell proteomics and transcriptomics. Developmental Cell. 2022;57:1400\u20131420.e7.","journal-title":"Developmental Cell"},{"key":"3085_CR14","doi-asserted-by":"publisher","first-page":"e0131285","DOI":"10.1371\/journal.pone.0131285","volume":"10","author":"Y Qu","year":"2015","unstructured":"Qu Y, Han B, Yu Y, Yao W, Bose S, Karlan BY, et al. Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells. PLoS ONE. 2015;10:e0131285.","journal-title":"PLoS ONE"},{"key":"3085_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/aja.2011.150","volume":"14","author":"E Castro","year":"2012","unstructured":"Castro E, Eeles R. The role of BRCA1 and BRCA2 in prostate cancer. Asian J Androl. 2012;14:409\u201314.","journal-title":"Asian J Androl"},{"key":"3085_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.aay0267","volume":"368","author":"WR Karthaus","year":"2020","unstructured":"Karthaus WR, Hofree M, Choi D, Linton EL, Turkekul M, Bejnood A, et al. Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science. 2020;368:497\u2013505.","journal-title":"Science"},{"key":"3085_CR17","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.2012.43.1882","volume":"31","author":"E Castro","year":"2013","unstructured":"Castro E, Goh C, Olmos D, Saunders E, Leongamornlert D, Tymrakiewicz M, et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol. 2013;31:1748\u201357.","journal-title":"J Clin Oncol"},{"key":"3085_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/gcc.20538","volume":"47","author":"L Antonova","year":"2008","unstructured":"Antonova L, Mueller CR. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer. Genes Chromosomes Cancer. 2008;47:341\u201352.","journal-title":"Genes Chromosomes Cancer"},{"key":"3085_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature10368","volume":"477","author":"MR Hara","year":"2011","unstructured":"Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, et al. A stress response pathway regulates DNA damage through beta(2)-adrenoreceptors and beta-arrestin-1. Nature. 2011;477:349\u2013U129.","journal-title":"Nature"},{"key":"3085_CR20","doi-asserted-by":"publisher","first-page":"i44","DOI":"10.1093\/annonc\/mdq665","volume":"22","author":"E Warner","year":"2011","unstructured":"Warner E. Impact of MRI surveillance and breast cancer detection in young women with BRCA mutations. Ann Oncol. 2011;22:i44\u20139.","journal-title":"Ann Oncol"},{"key":"3085_CR21","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1017\/S0033291709992285","volume":"40","author":"M Pinquart","year":"2010","unstructured":"Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychological Med. 2010;40:1797\u2013810.","journal-title":"Psychological Med"},{"key":"3085_CR22","first-page":"1756","volume":"83","author":"BM Kudielka","year":"1998","unstructured":"Kudielka BM, Hellhammer J, Hellhammer DH, Wolf OT, Pirke K-M, Varadi E, et al. Sex Differences in Endocrine and Psychological Responses to Psychosocial Stress in Healthy Elderly Subjects and the Impact of a 2-Week Dehydroepiandrosterone Treatment1. J Clin Endocrinol Metab. 1998;83:1756\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"3085_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3803\/EnM.2022.1549","volume":"37","author":"MH Choi","year":"2022","unstructured":"Choi MH. Clinical and Technical Aspects in Free Cortisol Measurement. Endocrinol Metab (Seoul). 2022;37:599\u2013607.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"3085_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF00207507","volume":"74","author":"S Loft","year":"1996","unstructured":"Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med (Berl). 1996;74:297\u2013312.","journal-title":"J Mol Med (Berl)"},{"key":"3085_CR25","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1530\/EC-17-0160","volume":"6","author":"F Roelfsema","year":"2017","unstructured":"Roelfsema F, van Heemst D, Iranmanesh A, Takahashi P, Yang R, Veldhuis JD. Impact of age, sex and body mass index on cortisol secretion in 143 healthy adults. Endocr Connect. 2017;6:500\u20139.","journal-title":"Endocr Connect"},{"key":"3085_CR26","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP161370.OR","volume":"22","author":"Y Sofer","year":"2016","unstructured":"Sofer Y, Osher E, Limor R, Shefer G, Marcus Y, Shapira I, et al. Gender determines serum free cortisol: higher levels in men. Endocr Pr. 2016;22:1415\u201321.","journal-title":"Endocr Pr"},{"key":"3085_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0729-6","volume":"10","author":"B Herhaus","year":"2020","unstructured":"Herhaus B, Ullmann E, Chrousos G, Petrowski K. High\/low cortisol reactivity and food intake in people with obesity and healthy weight. Transl Psychiatry. 2020;10:40.","journal-title":"Transl Psychiatry"},{"key":"3085_CR28","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3390\/ijms12053117","volume":"12","author":"A Fern\u00e1ndez-S\u00e1nchez","year":"2011","unstructured":"Fern\u00e1ndez-S\u00e1nchez A, Madrigal-Santill\u00e1n E, Bautista M, Esquivel-Soto J, Morales-Gonz\u00e1lez A, Esquivel-Chirino C, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011;12:3117\u201332.","journal-title":"Int J Mol Sci"},{"key":"3085_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.bbi.2024.10.022","volume":"123","author":"JL Hansen","year":"2025","unstructured":"Hansen JL, Carroll JE, Seeman TE, Cole SW, Rentscher KE. Lifetime chronic stress exposures, stress hormones, and biological aging: Results from the Midlife in the United States (MIDUS) study. Brain Behav Immun. 2025;123:1159\u201368.","journal-title":"Brain Behav Immun"},{"key":"3085_CR30","doi-asserted-by":"publisher","first-page":"eade1857","DOI":"10.1126\/scitranslmed.ade1857","volume":"15","author":"P Bhardwaj","year":"2023","unstructured":"Bhardwaj P, Iyengar NM, Zahid H, Carter KM, Byun DJ, Choi MH, et al. Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2. Sci Transl Med. 2023;15:eade1857.","journal-title":"Sci Transl Med"},{"key":"3085_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-828","volume":"13","author":"J Mouchacca","year":"2013","unstructured":"Mouchacca J, Abbott GR, Ball K. Associations between psychological stress, eating, physical activity, sedentary behaviours and body weight among women: a longitudinal study. BMC Public Health. 2013;13:828.","journal-title":"BMC Public Health"},{"key":"3085_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3389\/fphar.2018.00909","volume":"9","author":"H Chen","year":"2018","unstructured":"Chen H, Wu J, Zhang Z, Tang Y, Li X, Liu S, et al. Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis. Front Pharm. 2018;9:909.","journal-title":"Front Pharm"},{"key":"3085_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/modpathol.2010.200","volume":"24","author":"S Badve","year":"2011","unstructured":"Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011;24:157\u201367.","journal-title":"Mod Pathol"},{"key":"3085_CR34","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm.2000","volume":"15","author":"E Lim","year":"2009","unstructured":"Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009;15:907\u201313.","journal-title":"Nat Med"},{"key":"3085_CR35","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3389\/fonc.2019.00820","volume":"9","author":"J Zhou","year":"2019","unstructured":"Zhou J, Chen Q, Zou Y, Chen H, Qi L, Chen Y. Stem cells and cellular origins of breast cancer: updates in the rationale, controversies, and therapeutic Implications. Front Oncol. 2019;9:820.","journal-title":"Front Oncol"},{"key":"3085_CR36","doi-asserted-by":"publisher","first-page":"11256","DOI":"10.1073\/pnas.190353897","volume":"97","author":"S Yeh","year":"2000","unstructured":"Yeh S, Hu YC, Rahman M, Lin HK, Hsu CL, Ting HJ, et al. Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proc Natl Acad Sci USA. 2000;97:11256\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3085_CR37","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.1073\/pnas.1132020100","volume":"100","author":"S Shin","year":"2003","unstructured":"Shin S, Verma IM. BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription. Proc Natl Acad Sci. 2003;100:7201\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"3085_CR38","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","volume":"155","author":"VK Arora","year":"2013","unstructured":"Arora VK, Schenkein E, Murali R, Subudhi SK, Wongvipat J, Balbas MD, et al. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell. 2013;155:1309\u201322.","journal-title":"Cell"},{"key":"3085_CR39","doi-asserted-by":"publisher","first-page":"305ps19","DOI":"10.1126\/scitranslmed.aac7531","volume":"7","author":"J Kach","year":"2015","unstructured":"Kach J, Conzen SD, Szmulewitz RZ. Targeting the glucocorticoid receptor in breast and prostate cancers. Sci Transl Med. 2015;7:305ps19.","journal-title":"Sci Transl Med"},{"key":"3085_CR40","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/annonc\/mdx264","volume":"28","author":"G Spera","year":"2017","unstructured":"Spera G, Fresco R, Fung H, Dyck JRB, Pituskin E, Paterson I, et al. Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE\/TRIO-012 study. Ann Oncol. 2017;28:1836\u201341.","journal-title":"Ann Oncol"},{"key":"3085_CR41","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41416-022-01891-7","volume":"127","author":"LL L\u00f8fling","year":"2022","unstructured":"L\u00f8fling LL, St\u00f8er NC, Sloan EK, Chang A, Gandini S, Ursin G, et al. \u03b2-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis. Br J Cancer. 2022;127:1086\u201396.","journal-title":"Br J Cancer"},{"key":"3085_CR42","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","volume":"26","author":"JG Hiller","year":"2020","unstructured":"Hiller JG, Cole SW, Crone EM, Byrne DJ, Shackleford DM, Pang J-MB, et al. Preoperative \u03b2-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial. Clin Cancer Res. 2020;26:1803\u201311.","journal-title":"Clin Cancer Res"},{"key":"3085_CR43","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1111\/jocn.17358","volume":"33","author":"X Tian","year":"2024","unstructured":"Tian X, Zhou X, Sun M, Yu NX, Peng Y, Zheng X, et al. The effectiveness of positive psychological interventions for patients with cancer: A systematic review and meta-analysis. J Clin Nurs. 2024;33:3752\u201374.","journal-title":"J Clin Nurs"},{"key":"3085_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63431-y","volume":"14","author":"SA Bogn\u00e1r","year":"2024","unstructured":"Bogn\u00e1r SA, Teutsch B, Bunduc S, Veres DS, Szab\u00f3 B, Fogarasi B, et al. Psychological intervention improves quality of life in patients with early-stage cancer: a systematic review and meta-analysis of randomized clinical trials. Sci Rep. 2024;14:13233.","journal-title":"Sci Rep"},{"key":"3085_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2019.05.027","volume":"459","author":"RL Flaherty","year":"2019","unstructured":"Flaherty RL, Intabli H, Falcinelli M, Bucca G, Hesketh A, Patel BA, et al. Stress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase. Cancer Lett. 2019;459:59\u201371.","journal-title":"Cancer Lett"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03085-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03085-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03085-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:09:26Z","timestamp":1756901366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03085-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9,21]]}},"alternative-id":["3085"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03085-3","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Professor Rosalind Eeles has the following conflicts of interest to declare: Honoraria from GU-ASCO, Janssen, University of Chicago, Dana Farber Cancer Institute USA as a speaker. Educational honorarium from Bayer and Ipsen, member of external expert committee to Astra Zeneca UK and Member of Active Surveillance Movember Committee. She is a member of the SAB of Our Future Health. She undertakes private practice as a sole trader at The Royal Marsden NHS Foundation Trust and 90 Sloane Street SW1X 9PQ and 280 Kings Road SW3 4NX, London, UK. The remaining authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The IMPACT study protocol was reviewed and approved by the West-Midlands Research and Ethics Committee in the UK (reference: 05\/MRE07\/25) and subsequently by each participating institution\u2019s local committee. All participants provided written consent, and the study was performed in accordance with the Declaration of Helsinki. The clinical studies are coordinated by the Institute of Cancer Research, London, UK. This project represents independent research supported by The National Institute for Health Research (NIHR) Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}